Gorman Brian's Form 4 filing
Opiant Pharmaceuticals, Inc. (OPNT) · filed Sep 14, 2021
- Accession no.
- 0001385508-21-000128
- Filed
- Sep 14, 2021
- Trade date
- Sep 14, 2021
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $25.0K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gorman BrianCIK 0001813451 | Other: General Counsel |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2021 | Common Stock | PPurchaseAcquired | +1,300 | $19.04 | +$24,752 | 21,574 | Direct | |
| Sep 14, 2021 | Common Stock | PPurchaseAcquired | +12 | $18.97 | +$227.64 | 21,586 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.